SPATA2
Basic information
Region (hg38): 20:49903391-49915529
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPATA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 44 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 2 | 0 |
Variants in SPATA2
This is a list of pathogenic ClinVar variants found in the SPATA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-49905630-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
20-49905711-G-C | not specified | Uncertain significance (Jul 26, 2022) | ||
20-49905788-C-T | not specified | Uncertain significance (Mar 14, 2023) | ||
20-49905840-A-T | not specified | Uncertain significance (Sep 15, 2021) | ||
20-49905858-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
20-49905861-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
20-49905872-G-T | not specified | Uncertain significance (Dec 22, 2023) | ||
20-49905906-C-T | not specified | Uncertain significance (Nov 22, 2022) | ||
20-49905912-C-T | not specified | Uncertain significance (Mar 26, 2024) | ||
20-49905951-T-G | not specified | Uncertain significance (Jun 10, 2024) | ||
20-49905993-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
20-49906011-T-C | not specified | Uncertain significance (Mar 20, 2024) | ||
20-49906013-C-T | not specified | Uncertain significance (May 15, 2024) | ||
20-49906071-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
20-49906088-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
20-49906091-G-C | not specified | Uncertain significance (Nov 07, 2022) | ||
20-49906185-C-G | not specified | Uncertain significance (Aug 23, 2021) | ||
20-49906199-T-C | not specified | Uncertain significance (Jun 02, 2023) | ||
20-49906206-C-T | not specified | Likely benign (Jun 16, 2023) | ||
20-49906208-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
20-49906256-G-C | not specified | Uncertain significance (May 24, 2023) | ||
20-49906274-C-T | not specified | Uncertain significance (Oct 03, 2022) | ||
20-49906279-C-A | not specified | Uncertain significance (Oct 03, 2022) | ||
20-49906322-A-G | not specified | Uncertain significance (Sep 20, 2023) | ||
20-49906329-C-T | not specified | Uncertain significance (Dec 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPATA2 | protein_coding | protein_coding | ENST00000422556 | 2 | 12153 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.979 | 0.0211 | 125593 | 1 | 3 | 125597 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.677 | 305 | 340 | 0.897 | 0.0000230 | 3349 |
Missense in Polyphen | 105 | 139.41 | 0.75315 | 1265 | ||
Synonymous | 1.16 | 134 | 152 | 0.880 | 0.0000105 | 1091 |
Loss of Function | 3.50 | 1 | 16.2 | 0.0617 | 9.35e-7 | 193 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000911 | 0.0000909 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000908 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000329 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Bridging factor that mediates the recruitment of CYLD to the LUBAC complex, thereby regulating TNF-alpha-induced necroptosis (PubMed:27307491, PubMed:27458237, PubMed:27545878, PubMed:27591049). Acts as a direct binding intermediate that bridges RNF31/HOIP, the catalytic subunit of the LUBAC complex, and the deubiquitinase (CYLD), thereby recruiting CYLD to the TNF- R1 signaling complex (TNF-RSC) (PubMed:27458237, PubMed:27545878, PubMed:27591049). Required to activate the 'Met-1'- (linear) and 'Lys-63'-linked deubiquitinase activities of CYLD (PubMed:27458237, PubMed:27591049). Controls the kinase activity of RIPK1 and TNF-alpha-induced necroptosis by promoting 'Met-1'- linked deubiquitination of RIPK1 by CYLD (By similarity). {ECO:0000250|UniProtKB:Q8K004, ECO:0000269|PubMed:27307491, ECO:0000269|PubMed:27458237, ECO:0000269|PubMed:27545878, ECO:0000269|PubMed:27591049}.;
- Pathway
- Necroptosis - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.263
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.85
Haploinsufficiency Scores
- pHI
- 0.329
- hipred
- Y
- hipred_score
- 0.690
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.917
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spata2
- Phenotype
- reproductive system phenotype; cellular phenotype; immune system phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- multicellular organism development;spermatogenesis;regulation of tumor necrosis factor-mediated signaling pathway;programmed cell death;regulation of inflammatory response;regulation of necroptotic process;protein K63-linked deubiquitination;protein linear deubiquitination
- Cellular component
- fibrillar center;nucleus;cytoplasm
- Molecular function
- molecular_function;protein binding